Education and Training
Imaging of Osteonecrosis With Ferumoxytol-Enhanced MRI
The goal of the project is to evaluate osteonecrosis before and after decompression surgery with ferumoxytol-enhanced MRI.
Stanford is currently accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- drug: Ferumoxytol-enhanced magnetic resonance imaging
- device: Magentic Resonance Imaging
Eligibility
Inclusion Criteria:
- Osteonecrosis
- planned decompression surgery with autologous stem cell transplant
Exclusion Criteria:
- Contraindications for magnetic resonance imaging
- Hemosiderosis/hemochromatosis ( patients can still be included in the non-ferumoxytol
arm)
Ages Eligible for Study
8 Years - 40 Years
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Anne Sawyer
650-302-2846
I'm interested